Cadence, Inc.
Jamie Messier has extensive experience in financial leadership roles, currently serving as Controller at Cadence Inc. since December 2012. Prior to this position, Jamie was the Chief Financial Officer at Isis Biopolymer, Inc. from February 2010 to December 2012. Earlier in Jamie's career, roles included Principal at Restivo Monacelli LLP from December 2006 to February 2010, Manager at Sansiveri, Kimball & McNamee, LLP between 1999 and 2006, and Senior Accountant at Sullivan and Company CPAs LLP from 1996 to 1999. Jamie earned a Bachelor of Science in Accounting and Finance from the University of Rhode Island - College of Business from 1988 to 1992.
This person is not in any teams
This person is not in any offices
Cadence, Inc.
Cadence is a full-service contract manufacturing partner for medical and drug delivery device OEMs worldwide. We provide end-to-end product realization solutions for best-in-class total value, including: • Full service contract manufacturing solutions • Finished devices • Complex sub-assemblies • Mission-critical components (plastics + metals) • Improved product performance and economics Together with our customers, employees, and shareholders, we provide advanced products using science and sound engineering to make an impact that matters. Cadence manufacturers custom OEM products and is a proven medical device contract manufacturer. In addition to expertise in medical, automotive, defense, and industrial markets, Cadence also provides: • High-performance Specialty Blades under the Endurium®, Optima®, Diamaze®, and Olfa® brands • Precision products for the life science market under the Cadence Science®, MICRO-MATE®, and PERFEKTUM® brands Cadence employs more than 700 people with headquarters in Staunton, VA and other locations in Connecticut, Pennsylvania, Rhode Island, Wisconsin, and Costa Rica.